FIELD: medicine.
SUBSTANCE: level of LP(a) is determined by additional processing of 0.3 ml of blood serum with 0.1% solution of Triton X-100 with 15 min incubation at 20°C. After that blood serum is incubated with solution of Sudan B for 1 hour in dark thermostat at 40°C and sample is introduced into hole in agarose gel with area 4×20 mm for LP electrophoresis with further fixation of electroforegrams, their drying, densitometry. In case of 40% or higher reduction of LP(a) level in comparison with initial level treatment of coronary heart disease is estimated as efficient.
EFFECT: increased accuracy of predicting coronary heart disease.
2 ex, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC HEART DISEASE TREATMENT | 2010 |
|
RU2439575C1 |
METHOD OF PREDICTING COURSE OF CORONARY HEART DISEASE | 2009 |
|
RU2402016C1 |
METHOD OF PREDICTING ISCHEMIC HEART DISEASE COURSE | 2010 |
|
RU2439576C1 |
METHOD OF ESTIMATING CLINICAL EFFECTIVENESS IN CHRONIC HEART DISEASE | 2009 |
|
RU2396567C1 |
METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2476883C1 |
METHOD OF DETERMINING FRACTIONS OF BLOOD LIPOPROTEINS IN PATIENTS WITH CORONARY HEART DISEASE | 2009 |
|
RU2400751C1 |
METHOD OF ESTIMATING EFFICIENCY OF ISCHEMIC HEART DISEASE TREATMENT | 2010 |
|
RU2439581C1 |
METHOD OF DETERMINING BLOOD LIPOPROTEIN FRACTIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2010 |
|
RU2439580C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2520755C1 |
METHOD FOR ESTIMATING CLINICAL EFFECTIVENESS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2462722C1 |
Authors
Dates
2010-09-27—Published
2009-02-02—Filed